US activist Peter Staley opens CROI: we must all be activists until the next US administration
27 February 2026. Related: Early access, Conference reports, Activism & advocacy.
2026
CROI 2026: Statement in support of science
27 February 2026. Related: Early access, Conference reports, Activism & advocacy.
CROI 2026: Once-daily oral BIC/LEN simplifies ART for those on complex combinations
25 February 2026. Related: Early access, Conference reports, Antiretrovirals.
Islatravir PrEP didn’t protect against M184V mutation in macaque study
24 February 2026. Related: Early access, Conference reports, HIV prevention and transmission, Drug resistance.
11 mg dose selected for once-monthly MK-8527 for phase 3 PrEP studies
24 February 2026. Related: Early access, Conference reports, HIV prevention and transmission.
Continued HIV protection from 2:1:1 PrEP dosing in gay and bisexual men in Paris
24 February 2026. Related: Early access, Conference reports, HIV prevention and transmission.
CROI 2026: Overview and research to watch out for
23 February 2026. Related: Early access, Conference reports.
CROI 2026: Introduction and main themes
21 February 2026. Related: Early access, Conference reports.
HPV and anal cancer in HIV+ gay men: new campaign in Manchester: anal HPV in gay men on PrEP
7 February 2026. Related: Journal scan, Coinfections and complications, Cancer and HIV.
US funding cuts set to drive 23 million excess deaths in the poorest countries by 2030
5 February 2026. Related: Journal scan, Early access, Treatment access.
Future meetings and webinars 2026
1 February 2026. Related: Future meetings.
Cobicistat (Tybost) discontinuation in UK by the end of 2026
29 January 2026. Related: Early access, Treatment alerts, Treatment access.
Do ATIs in HIV cure-related studies cause anxiety?
27 January 2026. Related: Journal scan, Early access, Cure-related research.
The Morning After: new podcast interviews UK community activists
25 January 2026. Related: Activism & advocacy, On the web.
Achieving greater HIV viral suppression and reducing stimulant use in San Francisco pilot programme
12 January 2026. Related: Journal scan, Early access, Coinfections and complications, Activism & advocacy.
Cancer and women living with HIV: results from D:A:D and RESPOND support including screening in routine HIV care
11 January 2026. Related: Journal scan, Early access, Women's health, Cancer and HIV.
Confirmed safety of kidney transplant when both recipient and donor are HIV positive
11 January 2026. Related: Journal scan, Early access, Coinfections and complications, Cancer and HIV, Hepatitis coinfection.
Neutralising antibodies wane two years after mpox infection or vaccination: protection persists
10 January 2026. Related: Journal scan, Early access, mpox.